Dr. Calum Archibald MacRae is Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital (BWH), a Professor of Medicine at Harvard Medical School, and an expert member of BWH’s Cardiovascular Genetics Program, which comprehensively evaluates, diagnoses and manages care for inherited cardiac disorder patients. In addition, he is a leading investigator at the BWH Genomics Center and an associate professor of medicine at Harvard Medical School.He received his medical degree from University of Edinburgh College of Medicine. He completed two internal medicine residency programs: one at Wellcome Trust Centre for Neuroimaging in London and the other at BWH. He then completed a fellowship in cardiovascular disease at Massachusetts General Hospital. Dr. MacRae is board certified in internal medicine and cardiovascular disease.Dr. MacRae is a cardiologist and geneticist whose clinical interests include investigating new phenotypes and how research findings—including genomics discoveries—can be systematically implemented into clinical care. His research focuses on the biology and genomics of cardiovascular disease, specifically the biological basis of different arrhythmia susceptibilities. He holds five patents, has authored over 160 peer-reviewed publications and received research funding from the National Institutes of Health’s National Human Genome Research Institute. Dr. Macrae is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Cardiac Ablation.

William Bachman is a Cardiologist in Jamaica Plain, Massachusetts. Dr. Bachman is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Heart Attack, Atrial Fibrillation, Apoplexy, and Ventricular Fibrillation.

Dr. Peter H. Stone is director of the Vascular Profiling Research Group and the Cardiovascular Division Faculty Mentorship Program at Brigham and Women’s Hospital. A cardiovascular medicine specialist, he is also a professor of medicine at Harvard Medical School.Dr. Stone received his medical degree from Weill Cornell Medical College. He completed an internal medicine residency at University of California, San Francisco Medical Center, a cardiology fellowship at Pacific Medical Center (now California Pacific Medical Center) and cardiology research fellowship at Peter Bent Brigham Hospital. Dr. Stone is board certified in internal medicine and cardiovascular disease.His research focuses on coronary artery disease (CAD), specifically the vascular biology of atherosclerosis, innovative strategies to risk-stratify individual coronary plaques and novel pharmacologic and device CAD therapies. He leads multicenter clinical trials investigating risk assessment of coronary plaques, and new anti-ischemia therapies. He has written over 190 peer-reviewed publications and received research funding from the National Institutes of Health. Dr. Stone is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Atrial Fibrillation, Sitosterolemia, Hypertension, Pacemaker Implantation, and Cardiac Ablation.

William Sauer is a Cardiologist in Jamaica Plain, Massachusetts. Dr. Sauer is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Arrhythmias, Ventricular Tachycardia, Atrial Fibrillation, Cardiac Ablation, and Pacemaker Implantation.

Christian T. Ruff, MD, MPH is the Director of General Cardiology in the Cardiovascular Division at Brigham and Women’s Hospital in Boston, MA and an Associate Professor of Medicine at Harvard Medical School. Dr. Ruff graduated from Harvard University, earned his medical degree at Johns Hopkins University School of Medicine, and his masters of public health from the Harvard School of Public Health. Dr. Ruff completed his internal medicine residency and cardiovascular medicine fellowship at the Brigham and Women’s Hospital.Dr. Ruff is a Senior Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group and serves the Director of the Genetics Core Laboratory and the Co-Chairman of the Clinical Events Committee. He has led a broad array of projects, ranging from investigator initiated studies of biomarkers and genetic variants to large clinical trials. Dr. Ruff has served on international clinical guideline committees and has been invited to give hundreds of lectures nationally and internationally. He has authored many scholarly articles, editorials, reviews, and book chapters that include the New England Journal of Medicine, Lancet, Journal of the American Medical Association, American Journal of Medicine, Circulation, Journal of the American College of Cardiology, and Nature Reviews Cardiology. Dr. Ruff is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Atrial Fibrillation, Heart Attack, Heart Failure, Cardiac Ablation, and Angioplasty.

Dr. Gregory Piazza is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an associate professor of medicine at Harvard Medical School (HMS).Dr. Piazza received his medical degree from University of Massachusetts Medical School. He completed a residency in internal medicine and fellowships in cardiology and advanced cardiovascular imaging at Beth Israel Deaconess Medical Center. He also served as chief medical resident at Beth Israel Deaconess Medical Center. He then completed a fellowship in vascular medicine at BWH. Dr. Piazza is board certified in internal medicine, cardiovascular disease, vascular medicine and echocardiography.Dr. Piazza’s practice focuses on the evaluation, management and prevention of venous thromboembolism (VTE), thrombosis-related infertility, and stroke prevention in atrial fibrillation. The author of over 140 peer-reviewed publications, his research investigates innovative treatment of VTE, thrombosis-related infertility, and prevention of stroke. Dr. Piazza has received research support from the National Institutes of Health."". Dr. Piazza is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Pulmonary Embolism, Deep Vein Thrombosis, Venous Thromboembolism (VTE), Embolectomy, and Thrombectomy.

Dr. Paul Zei is a Cardiac Electrophysiologist and Cardiologist at Brigham and Women’s Hospital. He is Director of the BWH Comprehensive Atrial Fibrillation Program, with a faculty appointment at Harvard Medical School.Dr. Zei earned his medical degree and a PhD at Stanford University. He then completed Internal Medicine Internship and Residency, Cardiology Fellowship, and Cardiac Electrophysiology Fellowship training at BWH. After briefly serving on the faculty at BWH, he moved to Stanford University, where he spent eleven years as a faculty member in Cardiology and Cardiac Electrophysiology. At Stanford, Dr. Zei developed a program in complex ablation, a research program in technology innovation, and he also served as the Director of Outpatient Cardiology and ECG services. Dr. Zei then returned to Boston to re-join the faculty at BWH and Harvard Medical School.Dr. Zei’s clinical interests focus on management of complex arrhythmias, with an emphasis on atrial fibrillation, catheter ablation of complex arrhythmias, and device implantation. In his role as Director of BWH’s Comprehensive Atrial Fibrillation Program, Dr. Zei brings together a multi-disciplinary approach to the management of patients with Atrial Fibrillation and leads several research initiatives to better understand and treat patients with this condition. Dr. Zei’s research interests are in understanding the basic underlying mechanisms of cardiac arrhythmias and developing new technologies to treat patients with cardiac arrhythmias. Dr. Zei is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Atrial Fibrillation, Ventricular Tachycardia, Arrhythmias, Cardiac Ablation, and Pacemaker Implantation.

Dr. Neal K. Lakdawala is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). He is also an instructor in medicine at Harvard Medical School (HMS).Dr. Lakdawala received his medical degree from The University of Texas HSCSA. He completed a residency and chief residency in internal medicine at Columbia-Presbyterian Medical Center, a clinical and research fellowship in cardiovascular disease at BWH and a master’s degree in epidemiology at the Harvard School of Public Health. Dr. Lakdawala is board certified in internal medicine, cardiovascular disease and advanced heart failure and transplant cardiology.His clinical expertise includes cardiomyopathy, cardiac sarcoidosis, congestive heart failure, cardiovascular genetics and heart transplantation. Dr. Lakdawala’s research and peer-reviewed publications investigate early phenotypes in genetic cardiomyopathy to identify physiology-based therapeutics for heart failure. He has received research funding from the National Institutes of Health’s Heart Failure Network. Dr. Lakdawala is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Dr. Piotr S. Sobieszczyk is a member of the interventional cardiology team at Brigham and Women’s Hospital (BWH). A cardiovascular specialist, he is also an instructor in medicine at Harvard Medical School.He received his medical degree from Columbia University College of Physicians and Surgeons. He completed an internal medicine residency at Massachusetts General Hospital, as well a peripheral arterial and venous interventions fellowship at BWH. He then completed fellowships in interventional cardiology and interventional vascular medicine at BWH. Dr. Sobieszczyk is board certified in internal medicine, cardiovascular disease and interventional cardiology.Dr. Sobieszczyk’s clinical interests include carotid artery disease, structural heart disease, ventricular assist devices and high-risk coronary intervention. His research focuses on the medical and endovascular management of complex cardiovascular disease, including the management of peripheral artery disease. He has received research funding from the National Institutes of Health. Dr. Sobieszczyk is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Peripheral Artery Disease, Aortic Valve Stenosis, Arterial Insufficiency, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Usha B. Tedrow is director of the Clinical Cardiac Electrophysiology Program at Brigham and Women’s Hospital’s (BWH) Heart Rhythm Program. A cardiovascular medicine specialist, she is also an assistant professor of medicine at Harvard Medical School (HMS).Dr. Tedrow received her medical degree from HMS. She completed an internal medicine residency and a cardiology fellowship at Massachusetts General Hospital. In addition, she completed a cardiac electrophysiology fellowship at BWH. Dr. Tedrow is board certified in internal medicine, cardiovascular disease and cardiac electrophysiology.Her clinical interests include atrial fibrillation, cardiac resynchronization and ventricular tachycardia. She is currently researching left ventricular mapping and pacing data to analyze novel ablation treatments for structural heart disease. In addition, Dr. Tedrow serves on the editorial board of Circulation: Arrhythmia and Electrophysiology, has authored over 120 peer-reviewed publications and has received research funding from the Heart Rhythm Society. Dr. Tedrow is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. Her top areas of expertise are Ventricular Tachycardia, Arrhythmias, Paroxysmal Supraventricular Tachycardia (PSVT), Cardiac Ablation, and Pacemaker Implantation.

Dr. Michael N. Singh is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an instructor in pediatrics at Harvard Medical School.Dr. Singh received his medical degree from Loma Linda University School of Medicine. He completed a combined residency in medicine/pediatrics at Medical College of Ohio Hospital (now The University of Toledo Medical Center). Dr. Singh then completed a cardiology fellowship at Baystate Medical Center and fellowships in adult congenital heart disease, congenital echocardiography, Marfan syndrome/related connective tissue disorders, and pulmonary hypertension at BWH and Boston Children's Hospital. He is board certified in internal medicine, pediatrics and cardiovascular disease.Dr. Singh’s clinical interests include congenital heart disease, connective tissue disorder and Marfan syndrome. The author of 11 peer-reviewed publications, his research focuses on Marfan syndrome, adults with congenital heart disease and aortic valve dysfunction. Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Marfan Syndrome, Bicuspid Aortic Valve, Congenital Heart Disease (CHD), and Truncus Arteriosus.

Dr. Justina C. Wu is a cardiovascular medicine specialist at Brigham and Women’s Hospital and an assistant professor of medicine at Harvard Medical School.Dr. Wu received her medical degree from Brown Medical School (now The Warren Alpert Medical School of Brown University). She completed a residency in internal medicine at Beth Israel Deaconess Medical Center and a fellowship in cardiovascular medicine at Massachusetts General Hospital. Dr. Wu is board certified in internal medicine and cardiovascular disease.Dr. Wu’s clinical expertise lies in translating innovations in echocardiography and medical engineering into improvements in patient diagnosis and care. In addition, she has written 30 peer-reviewed publications with her research focused on echocardiography and mitral regurgitation. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. Her top areas of expertise are Heart Murmurs, Arterial Embolism, Carotid Artery Disease, Cardiac Ablation, and Pacemaker Implantation.

Patrick T. O'Gara, MD, is the Director of Strategic Planning for the Cardiovascular Division at Brigham and Women’s Hospital, the Watkins Family Distinguished Chair in Cardiology and Professor of Medicine at Harvard Medical School. His clinical activities are focused on patients with valvular heart disease, other structural heart diseases and aortic diseases, although he also maintains a large practice of general cardiology. Since 2001, he has been named annually among the Top Doctors in Boston and the U.S.O'Gara served as President of the American College of Cardiology (ACC) in 2014-15. Additional ACC leadership positions include his roles as Co-Chair of the ACC 2012 Scientific Session program committee, co-directorship of the ACC Board Review Course for Certification and Recertification, and Editor-in-Chief of the ACC Self-Assessment Program (ACCSAP). He served as Chair of the American Heart Association's (AHA's) Council on Clinical Cardiology from 2003-2005 and as the inaugural Editor of Heart Insight magazine from 2006 to 2011. In 2011, he received the Paul Dudley White Award from the Boston Division of the AHA Founder's Affiliate and has also been recognized with the Laennec Master Clinician Award (2011) and the Laennec Clinician Educator Award (2012). O'Gara was Chair of the writing committee for the 2013 ACC/AHA Guideline for the Management of Patients with ST-Elevation MI and has participated in several other guideline, expert consensus, scientific advisory and appropriate use criteria writing groups.He is currently the Vice-Chair for the AHA/ACC Task Force on Clinical Practice Guidelines. He is also the Steering Committee Co-Chair of the National Heart, Lung, and Blood Institute's Cardiothoracic Surgery Network, which has completed 3 groundbreaking, randomized controlled trials in cardiac surgery. O’Gara serves as Associate Editor for JAMA Cardiology and is a member of the Editorial Boards of the Journal of the American College of Cardiology and Circulation. He has lectured widely and authored or co-authored over 250 original manuscripts, chapters, critical reviews, statements and editorials. Dr. O'gara is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Aortic Valve Stenosis, Mitral Valve Regurgitation, Bicuspid Aortic Valve, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Dr. Anju Nohria is the Director of the Cardio-Oncology Program at Dana-Farber Brigham Cancer Center and a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH). In addition, she is an Associate Professor of Medicine at Harvard Medical School (HMS).Dr. Nohria received her medical degree from HMS. She completed an internal medicine residency and was a chief resident at Yale-New Haven Hospital. She then completed both a cardiovascular medicine fellowship and a heart failure and transplantation fellowship at BWH. She is board certified in cardiovascular disease and heart failure and transplantation.Dr. Nohria’s clinical interests include cardio-oncology and heart failure and transplantation. The author of over 100 peer-reviewed publications, she currently researches how to evaluate, prevent and treat cardiovascular complications that can arise as a consequence of cancer therapy. Dr. Nohria is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. Her top areas of expertise are Myocarditis, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, Cardiac Ablation, and Heart Transplant.

Samuel Goldhaber is a Cardiologist in Boston, Massachusetts. Dr. Goldhaber is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Pulmonary Embolism, Venous Thromboembolism (VTE), Deep Vein Thrombosis, Embolectomy, and Thrombectomy.

Carolyn Ho is a Cardiologist in Boston,, Massachusetts. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. Her top areas of expertise are Familial Hypertrophic Cardiomyopathy, Sengers Syndrome, Cardiomyopathy, Atrial Fibrillation, and Pacemaker Implantation.

Robert Giugliano is a Cardiologist in Boston,, Massachusetts. Dr. Giugliano is rated as an Experienced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Atrial Fibrillation, Acute Coronary Syndrome, Heart Attack, Percutaneous Coronary Intervention (PCI), and Coronary Artery Bypass Graft (CABG).

Douglas Mah is a Pediatric Cardiologist in Boston, Massachusetts. Dr. Mah is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Heart Block, Congenital Heart Block, Arrhythmias, Cardiac Ablation, and Heart Transplant.

John Triedman is a Pediatric Cardiologist in Boston, Massachusetts. Dr. Triedman is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Heart Block, Wolff-Parkinson-White Syndrome, Congenital Heart Block, Cardiac Ablation, and Heart Transplant.

Edward Walsh is a Pediatric Cardiologist in Boston, Massachusetts. Dr. Walsh is rated as an Advanced provider by MediFind in the treatment of Brugada Syndrome. His top areas of expertise are Heart Block, Wolff-Parkinson-White Syndrome, Arrhythmias, Ebstein's Anomaly, and Cardiac Ablation.